EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 54 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $463,000 | -45.2% | 54,254 | -25.8% | 0.00% | -100.0% |
| Q4 2020 | $845,000 | +45.4% | 73,121 | +5.6% | 0.00% | – |
| Q3 2020 | $581,000 | -16.8% | 69,257 | -7.8% | 0.00% | -100.0% |
| Q2 2020 | $698,000 | +84.2% | 75,138 | +7.0% | 0.00% | – |
| Q1 2020 | $379,000 | -50.1% | 70,240 | +37.6% | 0.00% | -100.0% |
| Q4 2019 | $760,000 | +2614.3% | 51,052 | +1753.7% | 0.00% | – |
| Q3 2019 | $28,000 | 0.0% | 2,754 | +3.7% | 0.00% | – |
| Q2 2019 | $28,000 | +600.0% | 2,657 | +785.7% | 0.00% | – |
| Q2 2018 | $4,000 | -96.7% | 300 | -97.6% | 0.00% | – |
| Q1 2018 | $122,000 | +12100.0% | 12,484 | +12260.4% | 0.00% | – |
| Q4 2016 | $1,000 | – | 101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 217,029 | $2,225,000 | 6.42% |
| Knoll Capital Management, LLC | 350,238 | $3,590,000 | 3.29% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $7,840,000 | 3.01% |
| Broadfin Capital, LLC | 1,367,377 | $14,016,000 | 2.59% |
| P.A.W. CAPITAL CORP | 200,000 | $2,050,000 | 2.56% |
| 683 Capital Management, LLC | 1,860,529 | $19,071,000 | 2.12% |
| EcoR1 Capital, LLC | 1,060,043 | $10,865,000 | 1.37% |
| MANGROVE PARTNERS IM, LLC | 847,284 | $8,685,000 | 1.05% |
| KNOTT DAVID M | 234,448 | $2,403,000 | 1.01% |
| Trellus Management Company, LLC | 85,000 | $871,000 | 0.87% |